Dr. Albanus is a postdoctoral researcher at the Harari Lab at the Washington University School of Medicine Department of Psychiatry. His main research interests are understanding molecular mechanisms mediating genetic risk and resilience to neurodegenerative diseases. He pursues these goals using high-throughput molecular profiling assays at the bulk and single-cell levels.

Anant is a Ph.D. student in the computer science department at UIUC and works with the Data Science team at NIH and Data Tecnica International. He is interested in applying machine learning tools for aging and neurodegenerative disorders research. He analyzes multimodal biological datasets consisting of multi-omics, clinical measurements, and brain imaging.

Jeffrey L. Dage, Ph.D. is a Senior Research Professor of Neurology at Indiana University School of Medicine. He holds a secondary appointment in the Department of Medical and Molecular Genetics. He is the co-leader of the genetics biomarker and biosample core of the Indiana Alzheimer’s Research Center and of the Longitudinal Early Onset Alzheimer’s Disease Study. He is the Scientific Director of the National Centralized Repository for Alzheimer’s and Related Dementias (NCRAD). The current focus of his research is the discovery and development of biomarkers to aid in the understanding of neurodegenerative diseases. Prior to joining IUSM, Dr. Dage worked for Eli Lilly and Company for over 20 years where he pioneered the development of assays for measuring phosphorylated tau in blood.

Name: Linbin Dai, Ph.D. Position: Postdoctoral Fellow, Neuroimmunology Division of Life Sciences and Medicine Address: University of Science and Technology of China 443 Huangshan Road Hefei, Anhui, China email: dailinbin@ustc.edu.cn EDUCATION 2009 - 2013 Liaoning University, Shenyang, China B.S. Biotechnology 2013 - 2021 University of Science and Technology of China, Hefei, China Ph.D. Neurobiology 2021 - 2022 University of Science and Technology of China, Hefei, China Postdoc Fellow Neuroimmunology HONORS AND AWARDS 2009 National Encouragement scholarship 2014 Outstanding student leaders of USTC KEYWORDS/AREAS OF INTEREST Alzheimer's disease, aging, neurodegeneration, immune, biomarker.

PhD student

I am a postdoctoral researcher in Miia Kivipelto’s team, at the Department of Neurobiology, Care Sciences and Society, at Karolinska Institute in Sweden. My main research focus is to understand the complexity of Alzheimer’s disease pathology and the effects of prevention strategies, by identifying multi-biomarker profiles and molecular mechanisms that are related to these processes. I have an extensive training in protein biochemistry and biomarker assays. I graduated from School of Biology and School of Chemistry at Aristotle University of Thessaloniki in Greece and my MS and PhD studies focused on the role of the SR Protein Kinases (SRPKs) in leukaemia and Alzheimer's disease. I am also a member of the collaborative platform Nordic Brain Network, accounting around 100 researchers working with dementia in various centers of Excellence in Sweden, Finland and the UK.

prof . Ahmed Abdelrahman Daoud has completed his Ph.D. in Medical parasitology at the faculty of medicine Tanta University 1980. And another Ph.D. in Microbiology And Immunology in 1992 at Cairo Military Medical Academy .

PhD student (3rd year) at the Institute of Neurodegenerative diseases in Bordeaux, in the team of Dr. Erwan Bezard and under the supervision of Dr. Vincent Planche. My thesis is about the pathophysiology and modeling tauopathies in primates.

Drh Huda Shalahudin Darusman, MSi, PhD graduated as veterinarian from the Faculty of Veterinary Medicine at Bogor Agricultural University (Fakultas Kedokteran Hewan – Institut Pertanian Bogor, FKH-IPB) in Bogor-Indonesia in 2003 and he completed his doctorate degree in Universty of Copenhagen, Denmark. He has been a faculty staff of Faculty of Veterinary Medicine IPB since 2005 and became director of the Primate Research Center of IPB (PSSP-IPB) since 2017-present. Area of Speciality are Comparative Medicine, Pharmacology, Primatology, and Degenerative Diseases of Alzheimer’s type. Research and development projects over the last 5 years are Development of Elisa kit of amyloid beta 42 for Alzheimer diagnosis (2019-now), Principal Development of NHP model for Vaccine Human Papilloma Virus (2019-now), Principal Safety assessment of anti-cancer drugs of HER-2 monoclonal antibodies (2020 Co-principal), The Application of 4.0 Technologies in Thermal Infrared Sensors for Biomedical Research of Polio Vaccine (2019-2020), Principal Development of Immuno assays for rapid-detection of Covid-19 (2021-2022 principal). He has published several papers in relation with his expertise above and registered several patents from the research mentioned above.

Lois C.A. and Darwin E. Smith Distinguished Chair in Neurological Mobility Research. William T. Dauer, M.D., a neurologist acclaimed for his research into dystonia and Parkinson’s disease, joined UT Southwestern Medical Center in July 2019 as the inaugural Director of the Peter O’Donnell Jr. Brain Institute. Most recently, Dr. Dauer was Director of the Movement Disorders Group and the Morris K. Udall Center of Excellence for Parkinson’s Disease Research at the University of Michigan. For nearly two decades, Dr. Dauer’s groundbreaking research has focused on the molecular basis of dystonia and the mechanisms of neurodegeneration in Parkinson’s disease. His findings have elucidated the critical role of the torsinA protein in the progression of dystonia, which is marked by disabling, involuntary movements. The studies of his Udall Center team dissecting the neurobiologic basis of falls in Parkinson’s are being used to pioneer a therapy for this currently untreatable symptom. Dr. Dauer is an elected member of the American Society for Clinical Investigation, and has been honored with the Dystonia Medical Research Foundation’s Fahn Award and Columbia University’s Harold and Golden Lamport Award for excellence in clinical science research. He attended medical school at Washington University in St. Louis. After postdoctoral work at Massachusetts General Hospital and a medical internship at Beth Israel Hospital in Boston, he completed his residency in neurology and fellowship in Parkinson’s disease and related movement disorders at Columbia University in New York, where he established a laboratory in 2001. In 2009, he joined the faculty of the University of Michigan Medical School.